Sort
50,496 grants matching “lung cancer”
Genetic Epidemiology of Lung Cancer
$1,288,927University Of Cincinnati · U01 · FY2005 · CA
PLK1 and EGFR targeted nanoconstruct as a monotherapy and a radiation sensitizer for lung cancer
$1,288,251Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2025 · CA
Center of Excellence for High Throughput Proteogenomic Characterization
$1,288,045Steven A. Carr · Broad Institute, Inc. · U24 · FY2018 · CA
Center of Excellence for High Throughput Proteogenomic Characterization
$1,288,045Steven A. Carr · Broad Institute, Inc. · U24 · FY2016 · CA
Center of Excellence for High Throughput Proteogenomic Characterization
$1,288,045Steven A. Carr · Broad Institute, Inc. · U24 · FY2017 · CA
Deciphering microbial virulence mechanisms during Legionella pneumophila infection
$1,287,877Matthias Machner · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2018 · HD
Coordinating center for the NCI small cell lung cancer research consortium
$1,287,399Charles M Rudin · Sloan-Kettering Inst Can Research · U24 · FY2020 · CA
Kinase complexes in human diseases
$1,287,210Ping Zhang · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Preclinical Studies of Living and Deceased Donor Liver Allograft Tolerance
$1,286,273Megan Sykes · Columbia University Health Sciences · R01 · FY2025 · AI
Center of Excellence for High Throughput Proteogenomic Characterization
$1,286,216Steven A. Carr · Broad Institute, Inc. · U24 · FY2020 · CA
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models
$1,286,039Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
PROTECT - Harnessing PROTEin degradation for Advanced Childhood Tumors
$1,285,694Nathanael Schiander Gray · Stanford University · OT2 · FY2025 · CA
NYU BIOMARKER CLINICAL AND EPIDEMIOLOGIC CENTER
$1,283,443New York University School Of Medicine · U01 · FY2003 · CA
Ann Arbor regional CCOP
$1,282,877Saint Joseph Mercy Health System · U10 · FY2003 · CA
RAND-UCLA CanCORS PDCR Application
$1,282,820Rand Corporation · U01 · FY2004 · CA
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
$1,282,340Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Cancer Risk and Environmental Exposures
$1,281,824Mary H Ward · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Molecular Cytogenetics of Solid Tumors
$1,281,723Nicolae Popescu · Basic Sciences · Z01 · FY2007 · CA
Nutrition Intervention Trials in Linxian China
$1,281,038Philip Taylor · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA
Orphan Non-coding RNA-based Test for Detecting Minimal Residual Disease in Resectable Non-small Cell Lung Cancer
$1,280,908Babak Alipanahi · Exai Bio, Inc. · R44 · FY2024 · CA
Symptoms Clusters in Oncology Patients Receiving Chemotherapy
$1,280,902Christine A. Miaskowski · University Of California, San Francisco · R01 · FY2012 · CA
University of Texas PDX Development and Trial Center
$1,280,843Jack Roth · University Of Tx Md Anderson Can Ctr · U54 · FY2020 · CA
Design of Drugs Against Cancer and Viral Diseases
$1,280,818Christopher Michejda · Basic Sciences · Z01 · FY2007 · CA
PURPOSE: TO DETERMINE WHETHER A SEX DIFFERENCE EXISTS FOR RADIATIONINDUCED LUNG CANCERS ACROSS ALL AVAILABLE EXPOSED POPULATIONS. TO ADDRESS THE ISSUES OF TRANSFERRING RISKS FROM ONE EXPOSED POPULATION (E.G. THE JAPANESE ATOMIC BOMB SURVIVORS) TO ANOTHER (I.E. THE ASTRONAUT POPULATION). TO EVALUATE THE OPTIMUM WAYS FOR INCORPORATING THE SEXSPECIFIC LUNG CANCER RISKS INTO THE NASA LIFETIME RISK PROJECTION MODEL. TO PUBLISH AN NCRP COMMENTARY WITH RECOMMENDATION ON THE SEX-SPECIFIC LUNG CANCER RISK COEFFICIENTS TRANSFER MODELS AND LIFETIME CANCER RISK PROJECTIONS.
$1,280,770National Council On Radiation Protection & Measurements · · FY2020 · National Aeronautics and Space Administration
Molecular and Functional Characterization of Colon Tumor Cancer Stem Cells and St
$1,279,700Michael Clarke · Stanford University · U54 · FY2009 · CA